145 related articles for article (PubMed ID: 10980325)
1. Platelet 5-HT(2A) receptors in schizophrenic patients with and without neuroleptic treatment.
Govitrapong P; Chagkutip J; Turakitwanakan W; Srikiatkhachorn A
Psychiatry Res; 2000 Sep; 96(1):41-50. PubMed ID: 10980325
[TBL] [Abstract][Full Text] [Related]
2. Platelet serotonin transporter in schizophrenic patients with and without neuroleptic treatment.
Govitrapong P; Mukda S; Turakitwanakan W; Dumrongphol H; Chindaduangratn C; Sanvarinda Y
Neurochem Int; 2002 Oct; 41(4):209-16. PubMed ID: 12106771
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine serotonergic and dopaminergic responsivity in male schizophrenic patients during treatment with neuroleptics and after switch to risperidone.
Markianos M; Hatzimanolis J; Lykouras L
Psychopharmacology (Berl); 2001 Aug; 157(1):55-9. PubMed ID: 11512043
[TBL] [Abstract][Full Text] [Related]
4. Cortical and subcortical 5-HT2A receptor binding in neuroleptic-naive first-episode schizophrenic patients.
Erritzoe D; Rasmussen H; Kristiansen KT; Frokjaer VG; Haugbol S; Pinborg L; Baaré W; Svarer C; Madsen J; Lublin H; Knudsen GM; Glenthoj BY
Neuropsychopharmacology; 2008 Sep; 33(10):2435-41. PubMed ID: 18288096
[TBL] [Abstract][Full Text] [Related]
5. Ketanserin and spiperone as templates for novel serotonin 5-HT(2A) antagonists.
Glennon RA; Metwally K; Dukat M; Ismaiel AM; De los Angeles J; Herndon J; Teitler M; Khorana N
Curr Top Med Chem; 2002 Jun; 2(6):539-58. PubMed ID: 12052193
[TBL] [Abstract][Full Text] [Related]
6. Preliminary studies of human cortical 5-HT2 receptors and their involvement in schizophrenia and neuroleptic drug action.
Reynolds GP; Rossor MN; Iversen LL
J Neural Transm Suppl; 1983; 18():273-7. PubMed ID: 6135746
[TBL] [Abstract][Full Text] [Related]
7. Dysregulated 5-HT(2A) receptor binding in postmortem frontal cortex of schizophrenic subjects.
Muguruza C; Moreno JL; Umali A; Callado LF; Meana JJ; González-Maeso J
Eur Neuropsychopharmacol; 2013 Aug; 23(8):852-64. PubMed ID: 23176747
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological profiles of R-96544, the active form of a novel 5-HT2A receptor antagonist R-102444.
Ogawa T; Sugidachi A; Tanaka N; Fujimoto K; Asai F
Eur J Pharmacol; 2002 Dec; 457(2-3):107-14. PubMed ID: 12464356
[TBL] [Abstract][Full Text] [Related]
9. Altered platelet serotonin 5-HT2A receptor density but not second messenger inositol trisphosphate levels in drug-free schizophrenic patients.
Arranz B; Rosel P; Sarró S; Ramirez N; Dueñas R; Cano R; María Sanchez J; San L
Psychiatry Res; 2003 May; 118(2):165-74. PubMed ID: 12798981
[TBL] [Abstract][Full Text] [Related]
10. Occupancy of dopamine D(1), D (2) and serotonin (2A) receptors in schizophrenic patients treated with flupentixol in comparison with risperidone and haloperidol.
Reimold M; Solbach C; Noda S; Schaefer JE; Bartels M; Beneke M; Machulla HJ; Bares R; Glaser T; Wormstall H
Psychopharmacology (Berl); 2007 Feb; 190(2):241-9. PubMed ID: 17111172
[TBL] [Abstract][Full Text] [Related]
11. Expression of serotonin 5-HT(2A) receptors in the human cerebellum and alterations in schizophrenia.
Eastwood SL; Burnet PW; Gittins R; Baker K; Harrison PJ
Synapse; 2001 Nov; 42(2):104-14. PubMed ID: 11574947
[TBL] [Abstract][Full Text] [Related]
12. Platelet serotonin-2 receptors in schizophrenia: effects of illness and neuroleptic treatment.
Pandey SC; Sharma RP; Janicak PG; Marks RC; Davis JM; Pandey GN
Psychiatry Res; 1993 Jul; 48(1):57-68. PubMed ID: 8105499
[TBL] [Abstract][Full Text] [Related]
13. Serotonin(2A) receptors are reduced in the planum temporale from subjects with schizophrenia.
Pralong D; Tomaskovic-Crook E; Opeskin K; Copolov D; Dean B
Schizophr Res; 2000 Jul; 44(1):35-45. PubMed ID: 10867310
[TBL] [Abstract][Full Text] [Related]
14. The effect of streptozotocin-induced diabetes on dopamine2, serotonin1A and serotonin2A receptors in the rat brain.
Sumiyoshi T; Ichikawa J; Meltzer HY
Neuropsychopharmacology; 1997 Mar; 16(3):183-90. PubMed ID: 9138434
[TBL] [Abstract][Full Text] [Related]
15. A voxel-by-voxel analysis of [18F]setoperone PET data shows no substantial serotonin 5-HT(2A) receptor changes in schizophrenia.
Verhoeff NP; Meyer JH; Kecojevic A; Hussey D; Lewis R; Tauscher J; Zipursky RB; Kapur S
Psychiatry Res; 2000 Oct; 99(3):123-35. PubMed ID: 11068194
[TBL] [Abstract][Full Text] [Related]
16. The serotonin 5-HT(2A) receptor subtype does not mediate apomorphine-induced aggressive behaviour in male Wistar rats.
Skrebuhhova-Malmros T; Pruus K; Rudissaar R; Allikmets L; Matto V
Pharmacol Biochem Behav; 2000 Oct; 67(2):339-43. PubMed ID: 11124399
[TBL] [Abstract][Full Text] [Related]
17. Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients.
Nyberg S; Eriksson B; Oxenstierna G; Halldin C; Farde L
Am J Psychiatry; 1999 Jun; 156(6):869-75. PubMed ID: 10360125
[TBL] [Abstract][Full Text] [Related]
18. The effect of maternal ketanserin treatment on foetal 5-HT receptor function in umbilical cord artery of pre-eclamptic patients.
Hanff LM; Gupta S; MaassenVanDenBrink A; Steegers EA; Saxena PR; Vulto AG; Visser W
Neonatology; 2007; 92(4):240-7. PubMed ID: 17556842
[TBL] [Abstract][Full Text] [Related]
19. MAO inhibitory side effects of neuroleptics and platelet serotonin content in schizophrenic patients.
Mészáros Z; Borcsiczky D; Máté M; Tarcali J; Tekes K; Magyar K
J Neural Transm Suppl; 1998; 52():79-85. PubMed ID: 9564610
[TBL] [Abstract][Full Text] [Related]
20. Effect of loxapine on peripheral dopamine-like and serotonin receptors in patients with schizophrenia.
Singh AN; Barlas C; Saeedi H; Mishra RK
J Psychiatry Neurosci; 2003 Jan; 28(1):39-47. PubMed ID: 12587849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
